Case Review Focus Areas:   Whether the patient took Zantac (Ranitidine)? Did the patient develop cancer When and where was the injury diagnosed? The extent and duration of the cancer injury from Zantac Treatment/management of the Adverse Events (AE’s) as a result of the exposure to the Zantac Follow-up visits for management of complications/AEs